Insiders who reported open-market trades in the last 12 months at the companies Jack Bendheim files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
E. Thomas Corcoran - $318K in PAHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jack Bendheim is a corporate insider, tracked as Executive Chairman, Director, 10% Owner of PHIBRO ANIMAL HEALTH CORP (PAHC). InsiderAlpha holds 35 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jack Bendheim submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jack Bendheim been buying or selling stock?
Recorded transactions: 0 open-market purchases and 116 open-market sales ($31.55M) across all tracked filings.
Jack Bendheim is Executive Chairman, Director, 10% Owner of PHIBRO ANIMAL HEALTH CORP (PAHC). 35 SEC Form 4 filings on record going back to 2025, most recently on 10 August 2026. Most recent open-market trade: sold $100K of PAHC on 7 May 2026. Lifetime open-market sales: $31.55M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Jack Bendheim.
InsiderAlpha's records for Jack Bendheim go back to 2025: 35 primary Form 4 filings, an average of 17.5 per year. 133 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
